From: A systematic review of adult admissions to ICUs related to adverse drug events
Required data or study | Causality assessment methods | |||||
---|---|---|---|---|---|---|
 | Kramer and colleagues [25] | WHO [26] | Naranjo and colleagues [27] | Karch-Lasagna [28] | Hallas and colleagues [29] | Begaud and colleagues [30] |
Required data for causality assessment | L, Chron, D, R, LT, AEC | L, Chron, D, R, AEC, PP | L, Chron, D, R, Pl, DM, LT, AEC, Atcd, OE | L, Chron, D, R, AEC | Chron, D, R, LT, AET, Atcd | L, Chron, D, R, LT, AEC, PP |
Trunet and colleagues, 1986 [10] | de, 29.7% (30); pr, 45.6% (46); po, 20.8% (21); un, 3.9% (4) | Â | Â | Â | Â | Â |
IGICE, 1987 [11]a | Â | Â | Â | Â | Â | Â |
Nelson and Talbert, 1996 [12] | Â | Â | pr, 59.6% (31)b; po, 40.4% (21)b | Â | de, 15.3% (8)b; pr, 40.4% (21)b; po, 25% (13)b; un, 19.3% (10)b | Â |
Darchy and colleagues, 1999 [13] | Â | Â | Â | de, 34.1% (14); pr, 34.1% (14); po, 31.8% (13) | Â | Â |
Hammerman and Kapeliovich, 2000 [14] | Â | Â | Â | ND | Â | Â |
Lehmann and colleagues, 2005 [15] | Â | Â | Â | ND | Â | Â |
Grenouillet-Delacre and colleagues, 2007 [16] | Â | Â | ND | Â | Â | Very likely, 8.3% (11); likely, 51.5% (68); possible, 40.2% (53) |
Rivkin, 2007 [17] | Â | Â | de, 4.8% (1); pr, 80.9% (17); po, 14.3% (3) | Â | Â | Â |
Schwake and colleagues, 2009 [18] | Â | ND | Â | Â | Â | Â |
Mercier and colleagues, 2010 [19] | Â | Â | Â | ND | Â | Â |
Nazer and colleagues, 2013 [20]a | Â | Â | Â | Â | Â | Â |